Two Sigma Securities’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-16,100
Closed -$333K 3415
2024
Q2
$333K Buy
16,100
+3,700
+30% +$73.5K ﹤0.01% 1905
2024
Q1
$233K Sell
12,400
-8,700
-41% -$149K ﹤0.01% 2198
2023
Q4
$304K Buy
21,100
+2,900
+16% +$39.4K ﹤0.01% 1991
2023
Q3
$316K Buy
18,200
+2,400
+15% +$50K ﹤0.01% 1912
2023
Q2
$329K Buy
+15,800
New +$343K ﹤0.01% 1791
2022
Q4
Sell
-15,300
Closed -$358K 3066
2022
Q3
$358K Buy
+15,300
New +$462K 0.01% 1402

Other funds holding OGN

Two Sigma Securities's OGN Position: Q1 2026 in Review

Two Sigma Securities sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 39,951 shares — an estimated $286K sold.

Two Sigma Securities first reported a position in OGN in Q3 2022 and held it in 6 quarters. The position peaked at $366K in Q2 2023. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Two Sigma Securities reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 39,951 Organon & Co shares in Q1 2026, an estimated $286K.
  • Two Sigma Securities first reported a position in Organon & Co in Q3 2022 and held it in 6 quarters.
  • Two Sigma Securities's Organon & Co position peaked at $366K in Q2 2023.
  • 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.